Cargando…

Serum total indoxyl sulfate and clinical outcomes in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study

BACKGROUND: Uremic toxins are associated with various chronic kidney disease-related comorbidities. Indoxyl sulfate (IS), a protein-bound uremic toxin, reacts with vasculature, accelerating atherosclerosis and/or vascular calcification in animal models. Few studies have examined the relationship of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto, Suguru, Fuller, Douglas S, Komaba, Hirotaka, Nomura, Takanobu, Massy, Ziad A, Bieber, Brian, Robinson, Bruce, Pisoni, Ronald, Fukagawa, Masafumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023193/ https://www.ncbi.nlm.nih.gov/pubmed/33841868 http://dx.doi.org/10.1093/ckj/sfaa121

Ejemplares similares

Fibroblast Growth Factor 23 and Mortality Among Prevalent Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study
por: Komaba, Hirotaka, et al.
Publicado: (2020)

Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS)
por: Yamamoto, Suguru, et al.
Publicado: (2018)

Importance of Simultaneous Evaluation of Multiple Risk Factors for Hemodialysis Patients’ Mortality and Development of a Novel Index: Dialysis Outcomes and Practice Patterns Study
por: Kanda, Eiichiro, et al.
Publicado: (2015)

Potential therapeutic interventions for chronic kidney disease‐associated sarcopenia via indoxyl sulfate‐induced mitochondrial dysfunction
por: Enoki, Yuki, et al.
Publicado: (2017)

p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis
por: Hyun, Hye Sun, et al.
Publicado: (2013)

Association Between Indoxyl Sulfate and Dialysis Initiation and Cardiac Outcomes in Chronic Kidney Disease Patients
por: Takkavatakarn, Kullaya, et al.
Publicado: (2022)

Comment on Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358
por: Barreto, Fellype C., et al.
Publicado: (2017)

Indoxyl Sulfate and Incident Peripheral Artery Disease in Hemodialysis Patients
por: Lin, Ting-Yun, et al.
Publicado: (2020)

The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients
por: Wu, Ping-Hsun, et al.
Publicado: (2021)

Indoxyl Sulfate Contributes to Adipose Tissue Inflammation through the Activation of NADPH Oxidase
por: Tanaka, Shoma, et al.
Publicado: (2020)

A Retrospective Study on Erythropoiesis Stimulating Agent Dose Reducing Potential of an Anti‐Platelet Activation Membrane Dialyzer in Hemodialysis Patients
por: Kakuta, Takatoshi, et al.
Publicado: (2018)

Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients
por: Huang, Jeng-Yi, et al.
Publicado: (2016)

Associations of employment status and educational levels with mortality and hospitalization in the dialysis outcomes and practice patterns study in Japan
por: Imanishi, Yasuo, et al.
Publicado: (2017)

Differential Effects of Indoxyl Sulfate and Inorganic Phosphate in a Murine Cerebral Endothelial Cell Line (bEnd.3)
por: Stinghen, Andréa E. M., et al.
Publicado: (2014)

Indoxyl Sulfate Mediates the Low Inducibility of the NLRP3 Inflammasome in Hemodialysis Patients
por: Ho, Li-Chun, et al.
Publicado: (2021)

International and Racial Differences in Mineral and Bone Disorder Markers and Treatments Over the First 5 Years of Hemodialysis in the Dialysis Outcomes and Practice Patterns Study
por: Chan, Kevin, et al.
Publicado: (2019)

Effects of Sevelamer Hydrochloride on Uremic Toxins Serum Indoxyl Sulfate and P-Cresyl Sulfate in Hemodialysis Patients
por: Lin, Cheng-Jui, et al.
Publicado: (2017)

Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients
por: Bataille, Stanislas, et al.
Publicado: (2017)

Indoxyl Sulfate, a Uremic Endotheliotoxin
por: Lano, Guillaume, et al.
Publicado: (2020)

Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS
por: Komaba, Hirotaka, et al.
Publicado: (2021)

Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention
por: Goto, Shunsuke, et al.
Publicado: (2008)

Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
por: Komaba, Hirotaka, et al.
Publicado: (2021)

Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease
por: Fourdinier, Ophélie, et al.
Publicado: (2021)

Indoxyl Sulfate Contributes to mTORC1-Induced Renal Fibrosis via The OAT/NADPH Oxidase/ROS Pathway
por: Nakano, Takehiro, et al.
Publicado: (2021)

Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1
por: Enoki, Yuki, et al.
Publicado: (2016)

Association between Serum Indoxyl Sulfate Levels and Endothelial Function in Non-Dialysis Chronic Kidney Disease
por: Wang, Chih-Hsien, et al.
Publicado: (2019)

Publisher Correction: Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients
Publicado: (2017)

Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies
por: Leong, Sheldon C., et al.
Publicado: (2016)

Indoxyl sulfate impairs valsartan-induced neovascularization()
por: Kuo, Ko-Lin, et al.
Publicado: (2020)

Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis
por: Shyu, Jia-Fwu, et al.
Publicado: (2021)

Twice-Weekly Hemodialysis and Clinical Outcomes in the China Dialysis Outcomes and Practice Patterns Study
por: Yan, Yucheng, et al.
Publicado: (2018)

Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
por: Hamano, Takayuki, et al.
Publicado: (2022)

Response to Letter to the Editor From Sumi et al: “Lower Bone Turnover and Skeletal PTH Responsiveness in Japanese Compared to European Patients Receiving Hemodialysis”
por: Jørgensen, Hanne Skou, et al.
Publicado: (2022)

Sex-Specific Differences in Hemodialysis Prevalence and Practices and the Male-to-Female Mortality Rate: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
por: Hecking, Manfred, et al.
Publicado: (2014)

Role of Indoxyl Sulfate as a Predisposing Factor for Atrial Fibrillation in Renal Dysfunction
por: Aoki, Kohei, et al.
Publicado: (2015)

Optimizing the cost-effectiveness of treatment for chronic kidney disease-mineral and bone disorder
por: Goto, Shunsuke, et al.
Publicado: (2013)

The Global Impact of the COVID-19 Pandemic on In-Center Hemodialysis Services: An ISN-Dialysis Outcomes Practice Patterns Study Survey
por: Aylward, Ryan, et al.
Publicado: (2021)

Inverted U-Curve Association between Serum Indoxyl Sulfate Levels and Cardiovascular Events in Patients on Chronic Hemodialysis
por: Tsai, Ming-Hsien, et al.
Publicado: (2021)

Indoxyl Sulfate Alters the Humoral Response of the ChAdOx1 COVID-19 Vaccine in Hemodialysis Patients
por: Hou, Yi-Chou, et al.
Publicado: (2022)

WCN23-0089 SERUM INDOXYL SULFATE IS ASSOCIATED WITH COVID-19 INFECTION AND DISEASE SEVERITY IN HEMODIALYSIS PATIENTS
por: Stepanova MD, N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qh6si6pjrgr97mthfp2ldfupua